The current status of intestinal transplantation

Current Opinion in Organ Transplantation

Volumn 13, Issue 3, 2008, Pages 266-272

  Fryer, Jonathan P ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Intestinal failure; Intestinal transplant

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; DACLIZUMAB; FINGOLIMOD; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ANTIBODY;

CYTOMEGALOVIRUS INFECTION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE FUNCTION DISORDER; INTESTINE TRANSPLANTATION; LIVER DISEASE; LIVER GRAFT; MORBIDITY; MORTALITY; PARENTERAL NUTRITION; PATIENT SELECTION; POSTOPERATIVE INFECTION; PROGNOSIS; REVIEW; TREATMENT INDICATION; INTESTINE; ORGAN TRANSPLANTATION; PHYSIOLOGY; TRANSPLANTATION; VIRUS INFECTION;

CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; INTESTINES; ORGAN TRANSPLANTATION; PARENTERAL NUTRITION, HOME;

EID: 54549112006     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3282fd6901     Document Type: Review

References (59)

1. Carrel A. The transplantation of organs. A preliminary communication. J Am Med Assoc 1905; 45:239-214.
2. Lillehei R, Goott B, Miller F. The physiological response of the small bowel of the dog to ischemia including prolonged in vitro preservation of the bowel with successful replacement and survival. Ann Surg 1959; 150: 543-560.
3. Lillehei RC, Idezuki Y, Feemster JA, et al. Transplantation of stomach, intestine, and pancreas: experimental and clinical observation. Surgery 1967; 62:721-741.
4. Margreiter R. The history of intestinal transplantation. Transplant Rev 1997; 11:9-14.
5. Cohen Z, Silverman R, Wassef R, et al. Small intestine transplantation using cyclosporine. Report of a case. Transplantation 1986; 42:613-621.
6. Deltz E, Schroeder P, Gebhardt H, et al. Successful clinical small bowel transplantation: report of a case. Clin Transplant 1989; 3:89-94.
7. Goulet O, Revillon, Jan D, et al. Two and one-half-year follow-up after isolated cadaveric small bowel transplantation in an infant. Transplant Proc 1992; 24:1224.
8. Grant D, Wall W, Mimeault R, et al. Successful small-bowel liver transplantation. Lancet 1990; 335:181-184.
9. McAllister VC, Grant DR. Clinical small bowel transplantation. In: Grant DR, Woods RFM, editors. Small bowel transplantation. London: Edward Arnold; 1994. pp. 121-124.
10. Grant D, Abu-Elmagd K, Reyes J, et al. 2003 report of the Intestine Transplant Registry. A new era has dawned. Ann Surg 2005; 241:607-613.
11. O'Keefe SJ, Buchman AL, Fishbein TM, et al. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol 2006; 4:6-10.
12. Nightingale J. The short bowel syndrome. Eur J Gastroenterol Hepatol 1995; 7:514-520.
13. Buchman AL, Iyer K, Fryer J. Parenteral nutrition associated liver disease and the role for isolated intestine and intestine/liver transplantation. Hepatology 2006; 43:9-19.
14. Howard L, Ament M, Fleming R, et al. Current use and clinical outcomes of home parenteral and enteral nutrition therapies in the United States. Gastroenterology 1995; 109:355-365.
15. Messing B, Crenn P, Beau P, et al. Long term survival and parenteral nutrition dependence in adult patients with short bowel syndrome. Gastroenterology 1999; 117:1043-1050.
16. Cavicchi M, Beau P, Crenn P, et al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000; 132:525-532.
17. Chan S, McCowen KC, Bistrian BC, et al. Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition. Surgery 1999; 126:28-34.
18. Chungfat N, Dixler I, Cohran V, et al. Impact of parenteral nutrition-associated liver disease on intestinal transplant waitlist dynamics. J Am Coll Surg 2007; 205:755-761. Analysis of UNOS data summarizes the effect of liver disease on intestinal transplant listing practices and intestine transplant candidate outcomes.
19. Malone FR, Horslen SP. Medical and surgical management of the pediatric patient with intestinal failure. Curr Treat Options Gastroenterol 2007; 10:379- 390.
20. Sudan DL. Treatment of intestinal failure: intestinal transplantation. Nat Clin Pract Gastroenterol Hepatol 2007; 4:503-510.
21. Middleton SJ. Is intestinal transplantation now an alternative to home parenteral nutrition? Proc Nutr Soc 2007; 66:316-320.
22. Lopushinsky SR, Fowler RA, Kulkarni GS, et al. The optimal timing of intestinal transplantation for children with intestinal failure: a Markov analysis. Ann Surg 2007; 246:1092-1099. This important analysis used modeling techniques to determine the best strategy for managing intestinal failure in children.
23. Tzakis AG, Kato T, Levi DM, et al. 100 multivisceral transplants at a single center. Ann Surg 2005; 242:480-490.
24. Selvaggi G, Gaynor JJ, Moon J, et al. Analysis of acute cellular rejection episodes in recipients to primary intestinal transplantation: a single center, 11-year experience. Am J Transplant 2007; 7:1249-1257. This paper describes a single center analysis of rejection episodes in large series of transplants including comparison of intestine only, liver-intestine and multivisceral.
25. Kato T, Tzakis AG, Selvaggi G, et al. Transplantation of the spleen: effect of splenic allograft in human multivisceral transplantation. Ann Surg 2007; 246: 436-444. This paper describes a retrospective, single center analysis of outcomes with multivisceral transplants performed with and without spleens.
26. Bond GJ, Mazariegos GV, Sindhi R, et al. Evolutionary experience with immunosuppression in pediatric intestinal transplantation. J Pediatr Surg 2005; 40:274-279.
27. Kato T, Tzakis AG, Selvaggi G, et al. Intestinal and multivisceral transplantation in children. Ann Surg 2006; 243:756-764.
28. Dazzi A, Lauro A, Zanfi C, et al. Steroids in intestinal transplantation. Clin Transplant 2007; 21:265-268.
29. Tzakis A, Weppler D, Khan M, et al. Mycophenolate mofetil as primary and rescue therapy in intestinal transplantation. Transplant Proc 1998; 30:2677- 2679.
30. Fishbein TM, Florman S, Gondolesi G, et al. Intestinal transplantation before and after the introduction of sirolimus. Transplantation 2002; 73:1538- 1542.
31. Gondolesi G, Ghirardo S, Raymond K, et al. The value of plasma citrulline to predict mucosal injury in intestinal allografts. Am J Transplant 2006; 6:2786- 2790.
32. Sudan DL, Vargas L, Sun Y, et al. Calprotectin: a novel noninvasive marker for intestinal allograft monitoring. Ann Surg 2007; 246:311-315. This paper is a thoughtful analysis of the utility of stool calprotectin measurements for monitoring for rejection in intestinal transplants.
33. Lee RG, Nakamura K, Tsamandas AC, et al. Pathology of human intestinal transplantation. Gastroenterology 1996; 110:1820-1834.
34. Ruiz P, Bagni A, Brown R, et al. Histological criteria for the identification of acute cellular rejection in human small bowel allografts: results of the pathology workshop at the VIII international small bowel transplant symposium. Trans Proc 2004; 36:335-337.
35. Sugito K, Inoue M, Ikeda T, et al. Effect of FTY720 and ex vivo graft irradiation in rat small bowel transplantation: expression of mucosal addressin cell adhesion molecule-1. Surg Today 2008; 38:38-41.
36. Langrehr JM, Gube K, Hammer MH, et al. Short-term anti-CD4 plus anti-TNFa receptor treatment in allogeneic small bowel transplantation results in longterm survival. Transplantation 2007; 84:639-646.
37. Kusne S, Furukawa H, Abu-Elmagd K, et al. Infectious complications after small bowel transplantation in adults: and update. Transplant Proc 1996; 28:2761.
38. Bueno J, Green M, Kocoshis S, et al. Cytomegalovirus infection after intestinal transplantation in children. Clin Infect Dis 1997; 25:1078-1083.
39. Rowe DT, Qu L, Reyes J, et al. Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol 1997; 35:1612-1615.
40. Matsura T, Taguchi T, Hayashida M, et al. The influence of rejection on graft motility after intestinal transplantation in swine: the possibility of using this method for the real-time monitoring of acute cellular rejection. J Pediatr Surg 2007; 42:1377-1385.
41. Schaefer N, Tahara K, Schmidt J, et al. Resident macrophages are involved in intestinal transplantation-associated inflammation and motoric dysfunction of the graft muscularis. Am J Transplant 2007; 7:1062-1070. This important basic science study evaluated the role of inflammatory events in intestinal motility.
42. Fryer J, Kaplan B, Lown K, et al. Low bioavailability of cyclosporine microemulsion and tacrolimus in a small bowel transplant recipient. Transplantation 1999; 67:333-335.
43. Kim J, Fryer J, Craig RM. Absorptive function following intestinal transplantation. Dig Dis Sci 1998; 43:1925-1930.
44. Abu-Elmagd K, Todo S, Tzakis A, et al. Three years clinical experience with intestinal transplantation. J Am Coll Surg 1994; 179:385.
45. Farmer DG, McDiarmid, Edelstein S, et al. Improved outcome after intestinal transplantation at a single institution over 12 years. Transplant Proc 2004; 36:303-304.
46. Fishbein TM, Kaufman SS, Fiorman SS, et al. Isolated intestinal transplantation: proof of clinical efficacy. Transplantation 2003; 76:636-640.
47. Langnas A, Chinnakotla S, Sudan D, et al. Intestinal transplantation at the University of Nebraska medical center: 1990 to 2001. Transplant Proc 2002; 34:958-960.
48. Lacaille G, Vass N, Sauvat F, et al. Long-term outcome, growth and digestive function in children 2 to 18 years after intestinal transplantation. Gut 2007; 13 Dec [Epub ahead of print].
49. Fishbein T, Novitsky G, Mishra L, et al. NOD2 expressing bone marrow derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine. Gut 2007; 26 Oct [Epub ahead of print]. Important observations from clinical series identified the importance of the innate immune system in intestinal failure and in regulating rejection in intestinal allografts.
50. Wang M, Li Q, Wang J, et al. Intestinal tight junctions in allograft after small bowel transplantation. Transplant Proc 2007; 39:289-291.
51. Chen Y, Li X, Tian L, et al. Inhibition of sonic hedgehog signaling reduces chronic rejection and prolongs survival in a rat orthotopic small bowel transplantation model. Transplantation 2007; 83:1351-1357.
52. Zhang Z, Kaptanoglu L, Tang Y, et al. IP-10-induced recruitment of CXCR3 host T cells is required for small bowel allograft rejection. Gastroenterology 2004; 126:809-818.
53. Wang J, Dong Y, Sun JZ, et al. Donor lymphoid organs are a major site of alloreactive T-cell priming following intestinal transplantation. Am J Transplant 2006; 6:2563-2571. This interesting basic science study demonstrated that graft lymph nodes repopulated with recipient lymphocytes direct the rejection response against the intestinal allograft.
54. Todo S, Reyes J, Furukawa H, et al. Outcome analysis of 71 clinical intestinal transplantations. Ann Surg 1995; 222:270.
55. Gruessner RW, Nakhleh RE, Harmon JV, et al. Donor-specific portal blood transfusion in intestinal transplantation: a prospective, preclinical large animal study. Transplantation 1998; 66:164.
56. Silveria FP, Husain S, Kwak EJ, et al. Living donor liver transplantation with alemtuzumab induction and steroid-free tacrolimus therapy [abstract]. Transpl Infect Dis; 2007; 9:22-27.
57. Beggs KJ, Lyubimov A, Borneman JN, et al. Immunologic consequences of multiple high-dose administration of allogeneic mesenchymal stem cells to baboons. Cell Transplant 2006; 15:711-721.
58. Fishbein TM, Bodian CA, Miller CM. National sharing of cadaveric isolated intestinal allografts for human transplantation: a feasibility study. Transplantation 2000; 69:859-863.
59. Benedetti E, Baum C, Cicalese L, et al. Progressive functional adaptation of segmental bowel graft from living related donor. Transplantation 2001; 71:569-571.